Comparative Pharmacology
Head-to-head clinical analysis: DISPERMOX versus PENICILLIN G SODIUM.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DISPERMOX versus PENICILLIN G SODIUM.
DISPERMOX vs PENICILLIN G SODIUM
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity and disrupting peptidoglycan cross-linking.
Penicillin G inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity, and activating autolytic enzymes.
Adults: 1 g (as amoxicillin 875 mg + clavulanate 125 mg) orally every 12 hours for 7-10 days.
2-4 million units intravenously every 4 hours for moderate to severe infections; up to 24 million units/day for severe infections (e.g., meningitis, endocarditis).
None Documented
None Documented
Terminal elimination half-life 1.5 hours; prolonged in renal impairment.
30-60 minutes in normal renal function; prolonged to 7-10 hours in anuria.
Renal excretion 80% as unchanged drug, biliary/fecal 10%.
Primarily renal (60-90% unchanged) via glomerular filtration and tubular secretion; minor biliary/fecal (<10%).
Category C
Category A/B
Penicillin Antibiotic
Penicillin Antibiotic